{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"23"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"OG000","value":"462"},{"groupId":"OG001","value":"473"}]}],"title":">0"},{"categories":[{"measurements":[{"groupId":"OG000","value":"295"},{"groupId":"OG001","value":"313"}]}],"title":"<200"},{"categories":[{"measurements":[{"groupId":"OG000","value":"191"},{"groupId":"OG001","value":"183"}]}],"title":"≥200"}],"denoms":[{"counts":[{"groupId":"OG000","value":"486"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"description":"EGFR IHC Histoscore H-score = weighted sum of % 1+ cells, twice % 2+ cells, and three times % 3+ cells. IHC H-score criteria was used to assess participants with a low EGFR expression defined by a H-score cutoff value of \\<200 and participants with a high EGFR expression defined by a H-score of cutoff value of \\>=200.","groups":[{"description":"Necitumumab + Gemcitabine + Cisplatin\n\nNecitumumab: 800 mg I.V. infusion on Days 1 and 8 of every 3 week cycle.\n\nContinues until progressive disease, toxicity, noncompliance, or withdrawal.\n\nGemcitabine: 1250 mg/m2 on Days 1 and 8 of every 3 week cycle.\n\nContinues for a maximum of six cycles.\n\nCisplatin: 75 mg/m2 IV on Day 1 of every 3 week cycle.\n\nContinues for a maximum of six cycles.","id":"OG000","title":"Necitumumab + Gemcitabine + Cisplatin"},{"description":"Gemcitabine + Cisplatin\n\nGemcitabine: 1250 mg/m2 on Days 1 and 8 of every 3 week cycle.\n\nContinues for a maximum of six cycles.\n\nCisplatin: 75 mg/m2 IV on Day 1 of every 3 week cycle.\n\nContinues for a maximum of six cycles.","id":"OG001","title":"Gemcitabine + Cisplatin"}],"paramType":"NUMBER","populationDescription":"All randomized participants who received at least one dose of study drug and had evaluable data for EGFR IHC.","reportingStatus":"POSTED","timeFrame":"31 Months","title":"Number of Participants With an Epidermal Growth Factor Hormone (EGFR) Protein Expression Measured by Immunohistochemistry (IHC)","type":"SECONDARY","unitOfMeasure":"participants"}